World Health Organization Endorses Oxford's Life-Saving Malaria Vaccine

Novavax's Matrix-M adjuvant, licensed to the Serum Institute of India (SII), is a key ingredient in the second-ever malaria vaccine endorsed by the World Health Organization. The vaccine, called R21/Matrix-M, will help address the high demand for malaria vaccines in Africa. SII, the world's largest vaccine producer, is already producing doses and plans to scale up to 200 million doses over the next two years. The Serum Institute has also partnered with Aspen Pharmacare to produce multiple vaccines in Africa, contributing to the continent's self-reliance in vaccine manufacturing.